GOZZO, LUCIA
 Distribuzione geografica
Continente #
NA - Nord America 352
EU - Europa 344
AF - Africa 105
AS - Asia 50
OC - Oceania 1
SA - Sud America 1
Totale 853
Nazione #
US - Stati Uniti d'America 346
IE - Irlanda 164
IT - Italia 136
CI - Costa d'Avorio 56
SN - Senegal 41
CN - Cina 28
IN - India 12
UA - Ucraina 11
BE - Belgio 10
NG - Nigeria 8
DE - Germania 6
VN - Vietnam 6
CA - Canada 5
RU - Federazione Russa 5
FI - Finlandia 4
GB - Regno Unito 4
SG - Singapore 3
AU - Australia 1
BS - Bahamas 1
ES - Italia 1
FR - Francia 1
GR - Grecia 1
SE - Svezia 1
TR - Turchia 1
UY - Uruguay 1
Totale 853
Città #
Dublin 163
Ashburn 76
Chandler 66
Abidjan 56
Dakar 41
Boardman 24
Catania 20
Rome 20
Washington 19
Brussels 10
Pune 10
Campobasso 9
Milan 9
Abuja 8
Palermo 8
Cambridge 7
Lawrence 7
Andover 6
Seattle 6
Des Moines 5
Jacksonville 5
Assago 4
Assoro 4
Dong Ket 4
Gela 4
Reggio Calabria 4
Augusta 3
Lamezia Terme 3
Lappeenranta 3
Piazzola Sul Brenta 3
San Giovanni la Punta 3
Cernusco sul Naviglio 2
Formia 2
Hanoi 2
Hebei 2
Messina 2
Nanaimo 2
Nanjing 2
Shenyang 2
Barcelona 1
Berlin 1
Bremen 1
Civitavecchia 1
Cork 1
Cosenza 1
Council Bluffs 1
Easton 1
Esslingen am Neckar 1
Grafing 1
Helsinki 1
Hyderabad 1
Jiaxing 1
Kherson 1
Kunming 1
Lentini 1
Linguaglossa 1
London 1
Mascalucia 1
Melbourne 1
Melilli 1
Milazzo 1
Montevideo 1
Moscow 1
Mumbai 1
Nassau 1
New York 1
Ningbo 1
Odesa 1
Ottawa 1
Paris 1
Parma 1
Paternò 1
Rho 1
San Francisco 1
Singapore 1
Stockholm 1
Toronto 1
Wilmington 1
Totale 665
Nome #
Pegylated asparaginase-induced liver injury, a case-based review and data from pharmacovigilance 55
The antineoplastic drug flavopiridol reverses memory impairment induced by Amyloid-ß1-42 oligomers in mice 49
New Therapeutic Perspectives in the Treatment of Uveal Melanoma: A Systematic Review 45
Off-Label Use of Venetoclax in Patients With Acute Myeloid Leukemia: Single Center Experience and Data From Pharmacovigilance Database 41
Off-label use of drugs and adverse drug reactions in pediatric units: A prospective, multicenter study 40
Safety of Antiplatelet Agents: Analysis of ‘Real-World’ Data from the Italian National Pharmacovigilance Network 33
Fertility Preservation in Female Pediatric Patients With Cancer: A Clinical and Regulatory Issue 33
Long-term efficacy and safety profile of multiple injections of intravitreal dexamethasone implant to manage diabetic macular edema: A systematic review of real-world studies 31
Fluoxetine Protects Retinal Ischemic Damage in Mice 28
Efficacy and Safety of Subthreshold Micropulse Yellow Laser for Persistent Diabetic Macular Edema After Vitrectomy: A Pilot Study 27
Do the current performance-based schemes in Italy really work? "Success fee": a novel measure for cost-containment of drug expenditure 27
Farmacologia. Principi di base e applicazioni terapeutiche. F. Rossi, V. Cuomo, C. Riccardi. Capitolo 18. Sviluppo ed uso dei farmaci: dal laboratorio alla clinica. 26
Access to Innovative Neurological Drugs in Europe: Alignment of Health Technology Assessments Among Three European Countries 25
Linking the Price of Cancer Drug Treatments to Their Clinical Value 23
Non-vitamin K antagonist oral anticoagulation agents in patients with atrial fibrillation: Insights from Italian monitoring registries 22
EMA: l’ente che vigila sui medicinali che circolano nella Comunità Europea 21
How many chronic myeloid leukemia patients who started a frontline second-generation tyrosine kinase inhibitor have to switch to a second-line treatment? A retrospective analysis from the monitoring registries of the italian medicines agency (AIFA) 19
Health Technology Assessment of Advanced Therapy Medicinal Products: Comparison Among 3 European Countries 18
Response to Letter to the Editor by Dr. Garattini 18
COVID-19 Disease and Vitamin D: A Mini-Review 18
Beyond the budget silo approach: estimating health system sustainability for future dementia drugs 18
The dual blocker of FAAH/TRPV1 N-arachidonoylserotonin reverses the behavioral despair induced by stress in rats and modulates the HPA-axis 17
Venetoclax in Relapsed/Refractory Acute Myeloid Leukemia: Are Supporting Evidences Enough? 16
Dexamethasone Treatment for Covid-19, a Curious Precedent Highlighting a Regulatory Gap 16
Mortality rate in patients with chronic myeloid leukemia in chronic phase treated with frontline second generation tyrosine kinase inhibitors: a retrospective analysis by the monitoring registries of the Italian Medicines Agency (AIFA) 15
Bioequivalence, Drugs with Narrow Therapeutic Index and The Phenomenon of Biocreep: A Critical Analysis of the System for Generic Substitution 15
Periodontal Disease and Pregnancy: Correlation with Underweight Birth 15
4th ESPT Conference: pharmacogenomics and personalized medicine - research progress and clinical implementation 15
Rituximab in Multiple Sclerosis: Are We Ready for Regulatory Approval? 15
Use of Enoxaparin to Counteract COVID-19 Infection and Reduce Thromboembolic Venous Complications: A Review of the Current Evidence 14
Starting dose and dose adjustment of non-vitamin K antagonist oral anticoagulation agents in a nationwide cohort of patients with atrial fibrillation 13
Towards a European harmonization of health technology assessment recommendations executive paper of European regulatory conference focused on the EU commission proposal to harmonize HTA 12
Regulatory, scientific, and ethical issues arising from institutional activity in one of the 90 Italian Research Ethics Committees 12
Starting Dose Of Non-Vitamin K Antagonist Oral Anticoagulation Agents In Patients With Atrial Fibrillation: Data From Italian Monitoring Registries 12
The Potential Role of Heparin in Patients With COVID-19: Beyond the Anticoagulant Effect. A Review 11
THE 40TH CONGRESS OF THE ITALIAN PHARMACOLOGICAL SOCIETY (SIF) 11
Phase II, noncomparative, open label, multicenter, study of osimertinib, in patients with locally advanced or metastatic EGFR mutated, T790M undetectable or unknown non-small cell lung cancer (Stage IIIB-IV) after no immediate prior EGFR TKI (OSIRIS study) 11
Osservatorio Nazionale sull’impiego dei Medicinali. L’uso dei farmaci in Italia. Rapporto Nazionale Anno 2018. Roma: Agenzia Italiana del Farmaco, 2019 11
Osservatorio Nazionale sull’impiego dei Medicinali. L’uso dei farmaci in Italia. Rapporto Nazionale Anno 2019. Roma: Agenzia Italiana del Farmaco, 2020. 10
Attitude survey of spontaneous adverse drug-reaction reporting by general practitioners in Sicily 10
AIFA: l’ente che autorizza un nuovo farmaco, una nuova formulazione o una nuova indicazione in Italia 10
SARS-Cov-2 Damage on the Nervous System and Mental Health 9
The Regulatory Challenges for Drug Repurposing During the Covid-19 Pandemic: The Italian Experience 9
Anemia Mediterranea o talassemia: c’è qualcosa per evitare le trasfusioni? 9
Editorial: Innovation in ocular pharmacology 8
Scheda informativa Tocilizumab per uso endovenoso nel trattamento di pazienti gravi con COVID-19 8
La sclerosi multipla: una malattia invalidante con nuove possibilità di cura 8
Quali farmaci usare per l’età pediatrica? 7
Severe Gastrointestinal Toxicity Following the Use of Gilteritinib: A Case Series and Analysis of Postmarketing Surveillance Data 6
Più che una speranza, oggi è una certezza la possibilità di ridurre la gravità dell’atrofia muscolare spinale 5
Obesità e farmaci: quando servono e quali usare 4
null 4
Prevenzione e terapia dell’osteoporosi: quali farmaci sono utili e cosa c’è di nuovo 4
The therapeutic value of treatment for multiple sclerosis: analysis of health technology assessments of three European countries 3
Editorial: Innovative treatments for neuro-psychiatric diseases 3
Accesso ai medicinali innovativi per indicazioni neurologiche in Europa: allineamento delle valutazioni di Health Technology Assessment tra i Paesi Europei 2
Totale 967
Categoria #
all - tutte 4.689
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.689


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191 0 0 0 0 0 0 0 0 0 0 0 1
2019/20209 6 1 0 0 0 0 1 0 0 0 0 1
2020/202117 0 0 1 0 3 0 1 0 1 3 3 5
2021/202275 1 6 3 1 8 5 6 1 10 10 5 19
2022/2023508 8 11 4 10 81 101 31 104 120 2 24 12
2023/2024349 18 59 35 42 26 99 21 39 4 6 0 0
Totale 967